NetraMark (CSE:AIAI) Appoints Lawrence Guy to Board of Directors

TORONTO, ON — January 29, 2026 — Leads & Copy — NetraMark Holdings Inc. (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) has appointed Lawrence Guy to its Board of Directors, strengthening the board with his expertise in capital markets, investment management, and public-company governance.

Mr. Guy’s extensive experience includes financial leadership, fund management, and corporate development across both private and public markets. He is currently a Managing Director with Next Edge Capital, where he is responsible for strategic partnerships, corporate initiatives, and evaluating new investment opportunities.

Prior to his current role, Mr. Guy was a Vice President at Purpose Investments and held the position of Chief Financial Officer and Director of Navina Asset Management Inc. before its acquisition by Aston Hill Financial Inc. He also served as a Portfolio Manager at Aston Hill Financial Inc.

Mr. Guy holds a BA in Economics from the University of Western Ontario and is a Chartered Financial Analyst. In addition to his new role, he is a director of Emerita Resources Corp. (TSX-V: EMO), Lithium Ionic Corp. (TSX-V: LTH), Nobel Resources Corp. (TSX-V: NBLC) and Halcones Precious Metals Corp. (TSX-V: HPM).

George Achilleos, Chief Executive Officer of NetraMark, expressed his pleasure in welcoming Mr. Guy to the Board, citing his breadth of experience as highly valuable for advancing the company’s strategy and scaling its operations.

NetraMark is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions for the pharmaceutical industry. The company’s product offering uses a topology-based algorithm that parses patient data sets into subsets based on multiple variables. NetraMark uses a variety of ML methods to transform data into intelligent information, enabling the company to work with smaller datasets and accurately segment diseases and classify patients for drug sensitivity and treatment efficacy.

For more information, refer to NetraMark’s publicly available documents on SEDAR+.

Source: NetraMark

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.